Primary Immune Deficiency Disorder Clinical Trials

26 clinical trials for Primary Immune Deficiency Disorder across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Pathophysiology of Inborn Immunodeficiencies — RECRUITING
• Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs) — RECRUITING · PHASE1
• Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures — RECRUITING · PHASE2
• EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection — RECRUITING · PHASE2
• Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) — RECRUITING · PHASE2
• Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection — RECRUITING · PHASE2
• Observational Study of Subcutaneous Immunoglobulin (Cutaquig) in Patients With Primary and Secondary Immunodeficiency. — ACTIVE_NOT_RECRUITING
• Identification of New Inborn Errors of Immunity — COMPLETED
• Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases — COMPLETED · PHASE3
• Intensive Care Unit and Secondary and Primary Immune Deficiency — COMPLETED
• A Study About Low Blood Pressure in Patients With Primary Immunodeficiency Disease Treated With Immune Globulin Products — OTHER
• Investigation of Dental Health in Children With Neutrophil Defects: A Clinical Study — COMPLETED · NA
• Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant — ACTIVE_NOT_RECRUITING · PHASE1
• Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA) — OTHER
• Study of Octanorm Subcutaneous IG in Patients With PID — COMPLETED · PHASE3
• TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID — COMPLETED · PHASE2
• Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency — WITHDRAWN · PHASE3
• Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases — COMPLETED · PHASE3
• Primary Immunodeficiency in Kuwait — COMPLETED
• Gamma Globulin Observations and Outcomes Database for Patients With Primary Immunodeficiency Disease (GOOD-SHEPARD-PI) — TERMINATED
• Octagam 5% Versus Comparator Post Marketing Trial — COMPLETED
• The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease — COMPLETED · NA
• Immunological Characteristics of Patients With PID and IBD — OTHER
• Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD) — COMPLETED · PHASE3
• Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study) — COMPLETED · PHASE3
• Study of Vitamin D3 Substitution to Patients With Primary Immunodeficiency — COMPLETED · PHASE1

Refine this search